<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201110097745N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2011-11-22</date_registration>
      <primary_sponsor>Vice chancellor for research Kerman University medical Sciences</primary_sponsor>
      <public_title>Spinal anesthesia with Lidocain</public_title>
      <acronym></acronym>
      <scientific_title>Comparison duration of spinal anesthesia between Lidocain5% and Lidocain5% plus Epinephrine in chronic Opium addiction patients and non addiction patients in lower extremity orthopedic surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2010-07-27</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>210</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/8192</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Spinal anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Addiction patients were selected according to our inclusion and exclusion criteria.  All patients were visited the night before surgery and were informed about the study. In these patients were told to use their usual daily dose. All patients were NPO for 8 h before the scheduled surgical procedure. The anesthesiologist who performed the spinal anesthesia and documented the sensory level was blinded to the patient’s history of opium abuse. After standard monitoring (electrocardiogram, pulse oxymetry, noninvasive arterial blood pressure, and heart rate), the patients received 500–750 milliliter of lactated   solution over 10–15min. Spinal anesthesia were performed with the patient in the sitting position under appropriate aseptic conditions. The L3–4 inter space was funded and with a 24-gauge Sprotte spinal needle was inserted via a midline approach. The needle bevel was oriented cephalic, while 75 milligrams of Lidocaine 5% with dextrose 7.5%   was injected in some patients and 75 mg of Lidocaine 5% with dextrose 7.5% plus 0.2 milligrams   Epinephrine   was injected at a rate of 0.2 milliliter per second in other addicted patients. The patients were placed supine on surgical bed after drug injection. T6 level of sensory was achieved with the help of position maneuvers. Sensory level was assessed with pinprick flank of patient each 10 minute. The level of sensory was then checked and documented till sensory level received to T10. This time that decrease four level of sensory level was recorded and was based of our study. Intervention 2: Non Addiction patients were selected according to our inclusion and exclusion criteria.  All patients were visited the night before surgery and were informed about the study. All patients were NPO for 8 h before the scheduled surgical procedure. The anesthesiologist who performed the spinal anesthesia and documented the sensory level was blinded to the patient’s history of opium non abuse. After standard monitoring (electrocardiogram, pulse oxymetry, noninvasive arterial blood pressure, and heart rate), the patients received 500–750 milliliter of lactated   solution over 10-15min. Spinal anesthesia were performed with the patient in the sitting position under appropriate aseptic conditions. The L3–4 inter space was funded and with a 24-gauge Sprotte spinal needle was inserted via a midline approach. The needle bevel was oriented cephalic, while 75 milligrams of Lidocaine 5% with dextrose 7.5%   was injected in some patients, and 75 milligrams of Lidocaine 5%with dextrose 7.5% plus 0.2 milligrams   Epinephrine   was injected at a rate of 0.2 milliliter per second in other non addicted patients. The patients were placed supine on surgical bed after drug injection. T6 level of sensory was achieved with the help of position maneuvers. Sensory level was assessed with pinprick flank of patient each 10 minute. The level of sensory was then checked and documented till sensory level received to T10. This time that decrease four level of sensory level was recorded and was based of our study.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Afshin Mansourian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bahonar Hospital, Baghe Meli Square، Kerman</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 34 1222 8034</telephone>
        <email>Afshin.mansourian@yahoo.com</email>
        <affiliation>Kerman University of medical sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Doctor Mohamad Askarzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Neruscience research Center, BVL Jahad, Kerman</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 34 1222 8034</telephone>
        <email>Alirezaaskarzadeh@yahoo.com</email>
        <affiliation>Kerman university of medical Scienes</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Exclusion criteria:&#13;
1 –patients with higher or lower then sixth lumbar vertebrae's primary sensory level of anesthesia     &#13;
2- Individuals with BMI (Body Mass Index) more than 30 kg/m2 and less than 20 kg/m2&#13;
3- Alcohol abusers&#13;
4- Patients who refuse spinal anesthesia&#13;
5-patients with Less than one year of opium abusers in addicted group&#13;
6- Substance abuse in less than 2 last years for patients in non addicted group&#13;
7- Substance abusers other than opium&#13;
8- Patients who had developed neuropathy formerly or at present&#13;
Inclusion criteria:&#13;
1- Fifteen to sixty five years old men with 150 to 180 centimeters in height&#13;
2- Drug addicted individuals with a history of more than one year abuse; specifically those who had shown withdrawal symptoms with abstention of drugs.&#13;
3- Patients who didn't use to any narcotic substances in less than 2 last years &#13;
   **   All information is based on the patient's statements.</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>65 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>y48-3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Local anesthesia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Addiction patients were selected according to our inclusion and exclusion criteria.  All patients were visited the night before surgery and were informed about the study. In these patients were told to use their usual daily dose. All patients were NPO for 8 h before the scheduled surgical procedure. The anesthesiologist who performed the spinal anesthesia and documented the sensory level was blinded to the patient’s history of opium abuse. After standard monitoring (electrocardiogram, pulse oxymetry, noninvasive arterial blood pressure, and heart rate), the patients received 500–750 milliliter of lactated   solution over 10–15min. Spinal anesthesia were performed with the patient in the sitting position under appropriate aseptic conditions. The L3–4 inter space was funded and with a 24-gauge Sprotte spinal needle was inserted via a midline approach. The needle bevel was oriented cephalic, while 75 milligrams of Lidocaine 5% with dextrose 7.5%   was injected in some patients and 75 mg of Lidocaine 5% with dextrose 7.5% plus 0.2 milligrams   Epinephrine   was injected at a rate of 0.2 milliliter per second in other addicted patients. The patients were placed supine on surgical bed after drug injection. T6 level of sensory was achieved with the help of position maneuvers. Sensory level was assessed with pinprick flank of patient each 10 minute. The level of sensory was then checked and documented till sensory level received to T10. This time that decrease four level of sensory level was recorded and was based of our study</i_keyword>
      <i_keyword>Non Addiction patients were selected according to our inclusion and exclusion criteria.  All patients were visited the night before surgery and were informed about the study. All patients were NPO for 8 h before the scheduled surgical procedure. The anesthesiologist who performed the spinal anesthesia and documented the sensory level was blinded to the patient’s history of opium non abuse. After standard monitoring (electrocardiogram, pulse oxymetry, noninvasive arterial blood pressure, and heart rate), the patients received 500–750 milliliter of lactated   solution over 10-15min. Spinal anesthesia were performed with the patient in the sitting position under appropriate aseptic conditions. The L3–4 inter space was funded and with a 24-gauge Sprotte spinal needle was inserted via a midline approach. The needle bevel was oriented cephalic, while 75 milligrams of Lidocaine 5% with dextrose 7.5%   was injected in some patients, and 75 milligrams of Lidocaine 5%with dextrose 7.5% plus 0.2 milligrams   Epinephrine   was injected at a rate of 0.2 milliliter per second in other non addicted patients. The patients were placed supine on surgical bed after drug injection. T6 level of sensory was achieved with the help of position maneuvers. Sensory level was assessed with pinprick flank of patient each 10 minute. The level of sensory was then checked and documented till sensory level received to T10. This time that decrease four level of sensory level was recorded and was based of our study</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Duration of spinal anesthesia with Lidocain%5. Timepoint: after 10 minute. Method of measurement: after 10 minute with pinprick  on abdomen each 10 minute e %5.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Height. Timepoint: At the time of admit ion. Method of measurement: by patient report.</sec_outcome>
      <sec_outcome>Age. Timepoint: At the time of admit ion. Method of measurement: by patient report.</sec_outcome>
      <sec_outcome>Body weight. Timepoint: At the time of admit ion. Method of measurement: by patient report.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research Kerman University medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2011-05-25</approval_date>
        <contact_name>Ethics committee of Kerman University of medical sciences</contact_name>
        <contact_address>BVL Jahad, Neuroscience Research Center of Kerman medical University kerman  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
